Lantern Pharma (LTRN) Announces $7M Share Buyback

Go back to Lantern Pharma (LTRN) Announces $7M Share Buyback

Lantern Pharma Announces Share Repurchase Program

November 22, 2021 9:00 AM EST

DALLAS, Nov. 22, 2021 /PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN) ("Lantern" or the "Company"), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that its board of directors has authorized a share repurchase program to acquire up to $7 million of the Company's common stock. The Company may purchase common stock on the open market, through privately negotiated transactions, or otherwise, in compliance with the rules of the United States Securities and Exchange Commission and... More